Guo Yingshu, Cao Xiuping, Zheng Xiaofei, Abbas S K Jahir, Li Juan, Tan Weihong
Shandong Provincial Key Laboratory of Molecular Engineering, School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China.
School of Chemistry and Chemical Engineering, Linyi University, Linyi276005, China.
Natl Sci Rev. 2022 Jan 17;9(5):nwac006. doi: 10.1093/nsr/nwac006. eCollection 2022 May.
In recent years, nanocarriers based on nucleic acids have emerged as powerful and novel nanocarriers that are able to meet the demand for cancer-cell-specific targeting. Functional dynamics analysis revealed good biocompatibility, low toxicity and programmable structures, and their advantages include controllable size and modifiability. The development of novel hybrids has focused on the distinct roles of biosensing, drug and gene delivery, vaccine transport, photosensitization, counteracting drug resistance and functioning as carriers and logic gates. This review is divided into three parts: (i) DNA nanocarriers, (ii) RNA nanocarriers and (iii) DNA/RNA hybrid nanocarriers and their applications in nanobiology delivery systems. We also provide perspectives on possible future directions for growth in this field.
近年来,基于核酸的纳米载体已成为强大的新型纳米载体,能够满足癌细胞特异性靶向的需求。功能动力学分析显示其具有良好的生物相容性、低毒性和可编程结构,其优点包括尺寸可控和可修饰性。新型杂合体的开发集中在生物传感、药物和基因递送、疫苗运输、光致敏、对抗耐药性以及作为载体和逻辑门等不同作用上。本综述分为三个部分:(i)DNA纳米载体,(ii)RNA纳米载体,以及(iii)DNA/RNA杂合纳米载体及其在纳米生物学递送系统中的应用。我们还对该领域未来可能的发展方向提供了展望。